{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:07:31Z","timestamp":1746331651139,"version":"3.40.4"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","license":[{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,20]]},"abstract":"<jats:p>Myeloproliferative neoplasms (MPN) are chronic hematological disorders marked by the abnormal proliferation of bone marrow cells. The most commonly encountered forms are polycythemia vera (PV), primary myelofibrosis (PMF), and essential thrombocythemia (ET). These disorders are generally associated with increases in blood components, which can lead to conditions like splenomegaly, thrombosis, bleeding tendencies, and a heightened risk of progressing to acute leukemia. Previous research has indicated a possible link between immune cells and MPN, yet this association is still poorly understood. This study seeks to elucidate the causal relationship between immune cell characteristics and the development of MPN. In this study, we employed Mendelian randomization (MR) to investigate potential causal links between 731 immune cell traits and the risk of developing MPN, leveraging data from genome-wide association studies (GWAS). To ensure the robustness of our findings, we conducted extensive sensitivity analyses to assess heterogeneity and detect any pleiotropic effects. Moreover, we implemented a false discovery rate (FDR) correction to mitigate the risk of false positives that may result from the multiple hypothesis testing, thereby adjusting for any statistical biases due to multiple comparisons. The immune phenotype IgD on IgD<jats:sup>+<\/jats:sup> CD24<jats:sup>-<\/jats:sup> B cells demonstrated a statistically significant protective effect against MPN (PFDR\u2005=\u20050.047). Upon adjusting the significance threshold to PFDR\u2005&lt;\u20050.20, 16 immune cell phenotypes were significantly associated with MPN. Among these, 11 were found to exert a protective effect against MPN, 5 phenotypes were associated with an elevated risk of MPN. This research highlights a significant association between various immune cell phenotypes and the risk of developing MPN, thereby advancing our understanding of the intricate interplay between immune cell traits and the progression of MPN.<\/jats:p>","DOI":"10.1097\/md.0000000000040945","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T20:02:36Z","timestamp":1734724956000},"page":"e40945","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Causal relationship between 731 immune cells and the risk of myeloproliferative neoplasms: A 2-sample bidirectional Mendelian randomization study"],"prefix":"10.1097","volume":"103","author":[{"given":"Yao","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Trauma and Orthopaedic, Ningbo No.2 Hospital, Ningbo, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2994-6648","authenticated-orcid":false,"given":"Yang","family":"Fei","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Ningbo No.2 Hospital, Ningbo, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"100717","DOI":"10.1016\/j.blre.2020.100717","article-title":"Myeloproliferative neoplasms (MPNs).","volume":"42","author":"Godfrey","year":"2020","journal-title":"Blood Rev"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1056\/NEJMra1406186","article-title":"Myeloproliferative neoplasms.","volume":"376","author":"Spivak","year":"2017","journal-title":"N Engl J Med"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1056\/NEJMoa1716614","article-title":"Classification and personalized prognosis in myeloproliferative neoplasms.","volume":"379","author":"Grinfeld","year":"2018","journal-title":"N Engl J Med"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13045-021-01116-z","article-title":"Molecular pathogenesis of the myeloproliferative neoplasms.","volume":"14","author":"Greenfield","year":"2021","journal-title":"J Hematol Oncol"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ajh.23690","article-title":"How common are myeloproliferative neoplasms? A systematic review and meta-analysis.","volume":"89","author":"Titmarsh","year":"2014","journal-title":"Am J Hematol"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40164-018-0124-7","article-title":"The epidemiology and clinical characteristics of myeloproliferative neoplasms in Malaysia.","volume":"7","author":"Yap","year":"2018","journal-title":"Exp Hematol Oncol"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/joim.13019","article-title":"Incidence of myeloproliferative neoplasms: trends by subgroup and age in a population-based study in Sweden.","volume":"287","author":"Hultcrantz","year":"2020","journal-title":"J Intern Med"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00438-023-02071-9","article-title":"Assessing the causal relationship between immune traits and systemic lupus erythematosus by bi-directional Mendelian randomization analysis.","volume":"298","author":"Gu","year":"2023","journal-title":"Mol Genet Genomics"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","article-title":"Complex genetic signatures in immune cells underlie autoimmunity and inform therapy.","volume":"52","author":"Orr\u00f9","year":"2020","journal-title":"Nat Genet"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1186\/s12888-023-05081-4","article-title":"Causal role of immune cells in schizophrenia: Mendelian randomization (MR) study.","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Psychiatry"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1093\/hmg\/ddac052","article-title":"Thyroid function, pernicious anemia and erythropoiesis: a two-sample Mendelian randomization study.","volume":"31","author":"Kjaergaard","year":"2022","journal-title":"Hum Mol Genet"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"1171446","DOI":"10.3389\/fimmu.2023.1171446","article-title":"The causal effect of inflammatory bowel disease on diffuse large B-cell lymphoma: two-sample Mendelian randomization study.","volume":"14","author":"Lu","year":"2023","journal-title":"Front Immunol"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/ijc.34214","article-title":"Causal relationships between inflammatory factors and multiple myeloma: a bidirectional Mendelian randomization study.","volume":"151","author":"Wang","year":"2022","journal-title":"Int J Cancer"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10654-020-00622-7","article-title":"Mendel\u2019s laws, Mendelian randomization and causal inference in observational data: substantive and nomenclatural issues.","volume":"35","author":"Davey Smith","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement.","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population.","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation.","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13075-024-03266-0","article-title":"The causal relationship between immune cells and ankylosing spondylitis: a bidirectional Mendelian randomization study.","volume":"26","author":"Fei","year":"2024","journal-title":"Arthritis Res Ther"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"18010","DOI":"10.1038\/s41598-024-69104-0","article-title":"Causal role of immune cells in aplastic anemia: Mendelian randomization (MR) study.","volume":"14","author":"Fu","year":"2024","journal-title":"Sci Rep"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/ije\/dyx034","article-title":"MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data.","volume":"46","author":"Yavorska","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s11325-023-02940-y","article-title":"A Mendelian randomization study revealed a causal link between napping and deep vein thrombosis (DVT).","volume":"28","author":"Yan","year":"2024","journal-title":"Sleep Breath"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"1284723","DOI":"10.3389\/fmicb.2023.1284723","article-title":"Casual effects of gut microbiota on risk of infections: a two-sample Mendelian randomization study.","volume":"14","author":"Lyu","year":"2023","journal-title":"Front Microbiol"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"e84646","DOI":"10.7554\/eLife.84646","article-title":"Time-varying and tissue-dependent effects of adiposity on leptin levels: a Mendelian randomization study.","volume":"12","author":"Richardson","year":"2023","journal-title":"ELife"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/cei\/uxac090","article-title":"Cytokine production by human B cells: role in health and autoimmune disease.","volume":"210","author":"De Gruijter","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"e1011776","DOI":"10.1371\/journal.pcbi.1011776","article-title":"Examining B-cell dynamics and responsiveness in different inflammatory milieus using an agent-based model.","volume":"20","author":"Shin","year":"2024","journal-title":"PLoS Comput Biol"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41420-024-01889-5","article-title":"B cell memory: from generation to reactivation: a multipronged defense wall against pathogens.","volume":"10","author":"Syeda","year":"2024","journal-title":"Cell Death Discovery"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12929-019-0558-1","article-title":"Regulatory mechanisms of B cell responses and the implication in B cell-related diseases.","volume":"26","author":"Tsai","year":"2019","journal-title":"J Biomed Sci"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12026-015-8708-3","article-title":"The role of B-1 cells in inflammation.","volume":"63","author":"Aziz","year":"2015","journal-title":"Immunol Res"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"582657","DOI":"10.3389\/fimmu.2020.582657","article-title":"Phenotypes, functions, and clinical relevance of regulatory B cells in cancer.","volume":"11","author":"Shang","year":"2020","journal-title":"Front Immunol"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12964-024-01776-7","article-title":"The complex interplay of tumor-infiltrating cells in driving therapeutic resistance pathways.","volume":"22","author":"Li","year":"2024","journal-title":"Cell Commun Signal"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/icb.2008.14","article-title":"Monocyte-derived dendritic cells in innate and adaptive immunity.","volume":"86","author":"Le\u00f3n","year":"2008","journal-title":"Immunol Cell Biol"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"101410","DOI":"10.1016\/j.smim.2020.101410","article-title":"Dendritic cells in the tumor microenvironment: prognostic and theranostic impact.","volume":"48","author":"Verneau","year":"2020","journal-title":"Semin Immunol"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3390\/cancers13020167","article-title":"IL-12 family cytokines in cancer and immunotherapy.","volume":"13","author":"Mirlekar","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ccell.2022.05.006","article-title":"Exercise-induced engagement of the IL-15\/IL-15R\u03b1 axis promotes anti-tumor immunity in pancreatic cancer.","volume":"40","author":"Kurz","year":"2022","journal-title":"Cancer Cell"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.it.2022.08.004","article-title":"Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy.","volume":"43","author":"Ma","year":"2022","journal-title":"Trends Immunol"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.3389\/fimmu.2019.01818","article-title":"The TNF paradox in cancer progression and immunotherapy.","volume":"10","author":"Montfort","year":"2019","journal-title":"Front Immunol"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12032-009-9190-3","article-title":"TNF-alpha and its inhibitors in cancer.","volume":"27","author":"Zidi","year":"2010","journal-title":"Med Oncol"},{"key":"R39-20250503","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12964-023-01282-2","article-title":"The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways.","volume":"21","author":"Bakhtiyari","year":"2023","journal-title":"Cell Commun Signal"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.imbio.2014.12.010","article-title":"Myeloid dendritic cells: development, functions, and role in atherosclerotic inflammation.","volume":"220","author":"Chistiakov","year":"2015","journal-title":"Immunobiology"},{"key":"R41-20250503","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.3389\/fimmu.2019.02746","article-title":"Allies or enemies-the multifaceted role of myeloid cells in the tumor microenvironment.","volume":"10","author":"Haas","year":"2019","journal-title":"Front Immunol"},{"key":"R42-20250503","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.3390\/cells9092136","article-title":"Cytokine profiling in myeloproliferative neoplasms: overview on phenotype correlation, outcome prediction, and role of genetic variants.","volume":"9","author":"Masselli","year":"2020","journal-title":"Cells"},{"key":"R43-20250503","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","article-title":"Death by TNF: a road to inflammation.","volume":"23","author":"Van Loo","year":"2023","journal-title":"Nat Rev Immunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040945","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:29:06Z","timestamp":1746318546000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":42,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040945","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2024,12,20]]}}}